Subscribe to our mailing list

News

Budget Statement 2017:  Encouraging Investment in Growth Businesses

23-Nov-17

Budget Statement 2017: Encouraging Investment in Growth Businesses

Encouraging Investment in Growth Businesses

 

Yesterday afternoon, the Chancellor of the Exchequer, Philip Hammond, delivered his Autumn Budget Statement to Parliament. Following the conclusion of the Patient Capital Review, the budget proposes legislation to encourage more investment in growth businesses through VCT, EIS and SEIS.

Having reviewed the announcements, we can confirm that existing Triple Point VCT, EIS, ISA and Business Relief investments are not materially affected.

We set out below a summary of the 2017 Autumn Budget Statement announcements, where relevant to our current offerings, and provide an update on our open products.

 

1. Changes to VCT/EIS/SEIS rules


As widely anticipated the budget included a number of announcements of changes to the rules governing Venture Capital Trusts, the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme.

The changes are principally focussed on ensuring that future funding is directed towards investments with the potential for growth, and as such do not materially affect existing investments.

VCT, EIS and SEIS

As part of the Government’s move to encourage investment for growth, new investments made through EIS, SEIS and by VCTs must satisfy a “risk-to-capital” principles-based test, which will be based on an assessment that the investee company plans to grow and develop and that investors have a significant risk of capital loss. We welcome this principles-based approach, which we believe will be more effective in focussing funding to growth investment than expanding the list of excluded activities

Existing EIS investments and fully invested VCTs will not be affected.

For more information see our Budget Summary Document.


VCT only

There have been several changes to the detailed rules governing VCTs, which can be found in our Budget Summary Document. 

From next year VCTs will have to invest 30% of funds raised within one to two years and from 2019 the qualifying investment test will increase from 70% to 80%. Currently, the test is for 70% to be invested after two to three years. Furthermore, certain more favorable conditions applying to “old money” will be removed, and there are changes to the type of loans that VCTs can make to their investee companies.

These changes do not affect existing investments made by our VCTs or the VCTs’ investment strategies.


2. No Changes to BR or ISA rules 

There are no changes to Business Relief or to ISAs. The ISA limit remains at £20,000.  In its response to the Patient Capital Review the Government states that it supports BR for family businesses and in growth markets and will keep it under review.

 

Back

As with all investments, our products place capital at risk. Investor’s may not get back the full amount invested. Our products invest in unlisted or smaller company shares which are likely to have higher volatility and liquidity risks than quoted shares. Any tax reliefs referred to may be subject to change and tax treatment will depend on the individual circumstances of the investor. Any reference made to past performance or forecasted performance of our products is not reliable indicators of future results. Triple Point does not provide investment or tax advice, and information on this website should not be construed as such. Potential investors should seek specialist independent tax and financial advice before investing in any alternative investment. Nothing on this website constitutes an offer, or invitation to treat, or inducement for you to engage in any investment activity.

Triple Point is the trading name for the Triple Point Group which includes the following companies and associated entities: Triple Point Investment Management LLP registered in England & Wales no. OC321250, authorised and regulated by the Financial Conduct Authority no. 456597, Triple Point Administration LLP registered in England & Wales no. OC391352 and authorised and regulated by the Financial Conduct Authority no. 618187, and TP Nominees Limited registered in England & Wales no.07839571, all of 18 St. Swithin’s Lane, London, EC4N 8AD.